These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 15907291
1. A 1.3 kb promoter fragment confers spatial and temporal expression of utrophin A mRNA in mouse skeletal muscle fibers. Stocksley MA, Chakkalakal JV, Bradford A, Miura P, De Repentigny Y, Kothary R, Jasmin BJ. Neuromuscul Disord; 2005 Jun; 15(6):437-49. PubMed ID: 15907291 [Abstract] [Full Text] [Related]
4. Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Gramolini AO, Bélanger G, Thompson JM, Chakkalakal JV, Jasmin BJ. Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1300-9. PubMed ID: 11546668 [Abstract] [Full Text] [Related]
5. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Chakkalakal JV, Michel SA, Chin ER, Michel RN, Jasmin BJ. Hum Mol Genet; 2006 May 01; 15(9):1423-35. PubMed ID: 16551657 [Abstract] [Full Text] [Related]
10. Changes in acetylcholine receptor function induce shifts in muscle fiber type composition. Jin TE, Wernig A, Witzemann V. FEBS J; 2008 May 01; 275(9):2042-54. PubMed ID: 18384381 [Abstract] [Full Text] [Related]
11. Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link. Gramolini AO, Jasmin BJ. Bioessays; 1997 Sep 01; 19(9):747-50. PubMed ID: 9297964 [Abstract] [Full Text] [Related]
12. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Miura P, Jasmin BJ. Trends Mol Med; 2006 Mar 01; 12(3):122-9. PubMed ID: 16443393 [Abstract] [Full Text] [Related]
19. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Banks GB, Chamberlain JS. Curr Top Dev Biol; 2008 Mar 01; 84():431-53. PubMed ID: 19186250 [Abstract] [Full Text] [Related]